• Cannabis Investment Strategies Amidst Pending Rescheduling Changes

    Jordan Tritt ,CEO and co-founder of The Panther Group, joins Richard Zwicky to discuss investment strategies, regulatory changes in the cannabis industry, successful entrepreneurship markers, and relationship challenges.

    Jordan emphasizes transparency and preparation for shifts, while Richard Zwicky shares insights on strategic business structures. 

    31m - May 21, 2024
  • Getting Your Specialized Cannabis Credit Score

    Ctrust, led by Dotan Y Melech, offers a specialized cannabis credit score similar to FICO, essential for capital access in the industry. We delve into the significance of this scoring system, Dotan's asset management background, and insights on federal legalization's potential effects on business dynamics.

    Richard Zwicky highlighted the system's importance amid funding challenges and discussed compliance issues with EPA standards., plus they investigate legal aspects and implications of different schedules under EPA regulations.

    32m - May 7, 2024
  • Germany's Legalization of Adult Cannabis Use and The Future of European Expansion

    Stephen Murphy, Co-Founder and Managing Director of Prohibition Partners speaks with Richard about Germany's legalization of adult cannabis use marking a significant development in Europe, impacting other countries. They discussed innovative mental health solutions leveraging AI to customize content for individuals and measure therapy effectiveness. Challenges in the US cannabis market were highlighted, attributing complexity to state regulations, federal laws, and business obstacles. Insights covered industry trends like changes in import markets, evolving consumer perceptions, and challenges faced by investors and companies. Key themes emphasized evidence-based mental health treatments, strategic business growth amidst global regulatory changes, and fostering collaboration across sectors. The Cannabis Europa Conference was recommended as a valuable networking opportunity in the industry landscape.

    32m - Apr 18, 2024
  • Ascend Wellness Holdings Strategy, Growth and Leveraging Regulatory Changes

    Richard Zwicky speaks with Rebecca Conti Koar, EVP of Investor Relations and Strategy at AWH (Ascend Wellness Holdings)

    Richard talks to Rebecca about Ascend Wellness's recent earnings results, revenue growth, market penetration, and potential expansion plans for new stores or markets.

    They address topics like tax strategy, upcoming refinancing of a term loan, and an outlet retail strategy for value-oriented products. Richard mentions potential consolidation within the industry due to aggressive price normalization, noting state-imposed caps that may restrict further opportunities.

    They conclude by discussing implications for the industry over the next twelve to eighteen months, including consolidation possibilities and challenges posed by regulatory changes.

    Rebecca provides insights into Ascend Wellness Holdings' current performance and future outlook in the cannabis industry, covering strategic initiatives and market dynamics. Plus, they discuss financial results, growth strategies, expansion plans, and potential barriers to entry. They analyze the impact of state-imposed caps on industry consolidation and future challenges arising from regulatory changes.

    26m - Mar 20, 2024
  • Psychedelics Legalization and Investment

    Psychedelics Legalization and Investment as Richard Zwicky welcomes Dustin Robinson, Managing Principal of Iter Investments, Founding Partner of Mr. Cannabis Law and Co-Founder of Mr. Psychedelic Law.

    Dustin Robinson, Esq., CPA, is managing principal of psychedelics venture capital firm Iter Investments; founding partner of psychedelics and cannabis law firm Mr. Cannabis Law; and co-founder of psychedelics non-profit Mr. Psychedelic Law; for your consideration on any stories that you may working on.

    Robinson’s venture capital firm is an investor in MAPS and has worked closely with the organization, and his law firm represents many clinics and therapists that are planning to use MDMA once approved.

    As a starting point, Robinson said, “MAPS PBC New Drug Application submission to the FDA is a tremendous milestone for the psychedelic industry. It is the first NDA submission for psychedelic therapy and brings us one step closer to a paradigm shift in mental health. My expected timeline is FDA approval around August 2024; DEA approval by end of 2024; first patient dosed by mid-2025; private insurance coverage by the end of 2025; and MDMA-Assisted Therapy at scale in 2026. With MAPS PBC Phase 3 trial results demonstrating a significant improvement over current medicines for PTSD, I expect MDMA-Assisted Therapy to be a game-changer for veterans and others suffering from PTSD

    30m - Feb 21, 2024
  • Australia Opens Door for MDMA and Psilocybin To Treat PTSD and Depression

    In a historic move, Australia has become the first country to prescribe MDMA and psilocybin for PTSD and depression. Join your host, Richard Zwicky, as he sits down with the inspirational Tania de Jong AM, a multifaceted personality—singer, businesswoman, and social entrepreneur. Together with Peter Hunt, Tania co-founded Mind Medicine Australia, a registered charity pioneering the use of regulatory-approved psychedelic medicines for mental health.

    Discover the mission of Mind Medicine Australia, acting as the central hub connecting academia, government, medical practitioners, technology, philanthropy, and culture. Dive into the innovative approaches to treating mental health and promoting psychological well-being through the development of these groundbreaking medicines.

    26m - Feb 7, 2024
  • Focusing on Alternative Cannabinoids, Market Challenges, and Tennessee's Regulatory Landscape

    Richard Zwicky speaks with David Miller, the CEO of FlowGardens. David shares his background, transitioning from the financial and accounting space to the cannabis industry. He discusses how being in a state like Tennessee, which currently doesn't legally allow marijuana or cannabis production, has led FlowGardens to focus on alternative cannabinoids and unique genetics development. David emphasizes the importance of consumer education regarding these alternative cannabinoids and mentions specific ones like CBC, THCV, and CBDV.

    The conversation touches on studies supporting the potential health benefits of alternative cannabinoids, particularly CBG and CBC in combating cancer and having anti-inflammatory characteristics. David highlights the challenge of consumer education in a market that tends to focus on high THC percentages. He also discusses the need for presenting consumers with options that offer a more holistic approach to medicinal use, considering various cannabinoids' potential benefits.

    The interview also explores how Tennessee's regulatory landscape differs from other states, creating opportunities for FlowGardens to innovate and potentially sell products in non-legal states. David expresses optimism about the evolving market in Tennessee despite its current restrictions, and the conversation ends with a mention of the state's governor not being very favorable toward the cannabis industry in the past.

    26m - Jan 16, 2024
  • Germany Passes Landmark Bill Legalizing Cannabis

    Germany's Cabinet has passed a landmark bill legalizing cannabis. Richard Zwicky speaks with Niklas Kouparanis, Co-Founder and CEO of Bloomwell Group, a leading European cannabis company based in Frankfurt and a holding company for medical cannabis businesses and brands in Germany about the pivotal legislation.

    The reclassification of cannabis, which in the future will no longer be considered a narcotic even when it’s prescribed for medicinal purposes, also has a great deal of significance. This will be a milestone for doctors, patients and all other industry participants. The course has been set for better medical care and growth within the medical cannabis sector. By removing the bureaucratic hurdles associated with previously classifying cannabis as a narcotic, the legislation forecasts that pharmaceutical wholesalers trading medicinal cannabis can save an average of 2.3 million Euros annually. In the case of medical practices, the legislation estimates that the compliance costs will be reduced by around 719,000 Euros per year. This increase in efficiency will also benefit the patients, who will have access to medicinal cannabis at more affordable price points.

    33m - Dec 6, 2023
  • Accessibility to Medical Cannabis for Patients across Canada with Sora Care

    Richard Zwicky speaks with Erin Prosk, President and Co-founder of Sante Cannabis and Sora Care. Sante Cannabis is the only no-fee medical cannabis service covered by Quebec's public health insurance.

    She is considered a pioneer in her efforts to help Quebecers access medical cannabis. Now, she is looking to improve accessibility to medical cannabis for patients across Canada with the launch of Sora Care, of which she is also President and Co-founder.

    31m - Nov 29, 2023
  • Cannabis Sustainability and Environmental Impact Examined

    Cannabis Sustainability and Environmental Impact Examined as Richard welcomes Eloisa Lewis, the Founder of New Climate Culture discuss all of the variables that include water issues, energy usage, plastic pollution and more.

    A climate scientist and founder of New Climate Culture, Lewis leads a think tank that designs “disaster-proof” human environments using biomimicry and low-cost, high-yield protocols.

    32m - Nov 15, 2023
  • Which States Will Drive Cannabis Industry Growth in the U.S.?

    Richard Zwicky welcomes Roy Bingham (Co-Founder and CEO) and Michael Arrington (Principal Analyst) of BDSA to share their recent forecast update on Which States Will Drive Cannabis Industry Growth in the U.S.

    According to their update, the legal United States cannabis market is expected to grow 12% by the end of 2023, reaching $29.6 billion. By 2027, the U.S. is forecast to deliver $45 billion in total legal sales. The total global legal cannabis industry is predicted to reach $36.7 billion in 2023 (with 80% of sales from U.S. markets), growing at a compound annual growth rate (CAGR) of 13% from 2022 to 2027.

    37m - Nov 1, 2023
  • Entering the Plant Based Protein Space into Cannabis

    Richard speaks with a brand strategist who made the transition from the Plant Based Protein Space into Cannabis. Dean Harris, the Co-Founder and CMO of TabBrands.

    Dean Harris has an extensive background building brands and businesses. He has served as the Head of Marketing/Chief Marketing Officer for HotJobs, Vonage, Kayak, kgb and BlueCava, Three of these brands went public and two were acquired. Before his CMO work, he co-founded and ran a full-service ad agency in New York City and Connecticut with accounts that included: Coca-Cola, J&J, Citi and Sotheby’s.

    32m - Oct 18, 2023
  • Rank Really High and Full Service Web Marketing and Development for Cannabis Brands

    Richard Zwicky speaks with Dan Mondello, co-founder and CEO at Rank Really High, specializing Full Service Web Marketing and Development for Cannabis Brands.

    The company’s customized solutions include Native E-Commerce Websites, Search Engine Marketing (SEM), Search Engine Optimization (SEO), SEO Strategy, Google My Business Optimization (GMB), Analytics and Reporting, and more. Through conversion focused websites, and Pay-Per-Click (PPC) and SEM compliant campaigns, Rank Really High creates high conversion dispensary websites designed to drive organic search traffic and reach cannabis dispensary buyers. Dan's background draws from the automotive industry and he can discuss strategies and marketing tactics cannabis companies can utilize that mimic big box retailers like Walmart and Target.

    38m - Oct 4, 2023
  • Marimed MSO Growth Strategy and Expansion to Emerging Markets

    Richard Zwicky welcomes MariMed's cofounder and new CEO Jon Levine about the MSO which has a strong presence in Massachusetts, Ohio and Illinois, as well as emerging markets like Maryland and Missouri.

    While most MSOs are scuttling for brand equity and sales in prominent, oversaturated markets, MariMed has strategically built out its operations in locations that have been traditionally underserved. Through careful market research and planning, the company has excelled in building its presence in promising emerging markets ahead of the curve and building out and aligning its vertical operations effectively.

    While other MSOs are constantly shuffling their consumer brands and SKUs, MariMed's brands are time-tested and new products brought to market are intentional and innovative. Also, MariMed has avoided a lot of the price compression that has plagued the industry over the past year-plus. Of note, MariMed’s Nature’s Heritage  flower remains the #1 selling flower in Massachusetts and prices have not decreased.



    26m - Sep 20, 2023
  • Decarbonization and Carbon Negative Production of Advanced Carbon Materials

    Richard Zwicky discusses Decarbonization and Carbon Negative Production of Advanced Carbon Materials with Zachary Scott, the CEO of Green Carbon.

    GreenCarbon is a breakthrough decarbonization company, specializing in the world’s first scalable and carbon negative production of Advanced Carbon Materials (ACM).

    GreenCarbon provides an alternative and sustainable method of creating high-value, cost-effective, materials from various agricultural waste streams, rich in photosynthesized carbon, reducing the concentration of carbon dioxide in our atmosphere. 

    GreenCarbon reduces industrial input costs and eliminates dependencies on transcontinental imports by sourcing waste domestically, enabling the continued reduction of emissions for millennia.

    30m - Aug 22, 2023
  • Andrew DeAngelo and the Future of Psychedelics

    Andrew DeAngelo joins the Green Peak to follow-up after the Psychedelic Science Conference where scientists and activists convened at a massive conference in Denver back in June to declare a renaissance for drugs like psilocybin and MDMA.

    We also discuss the predictions he penned in a Rolling Stone article that gave his 2023 Cannabis And Psychedelic Forecast.

    43m - Aug 2, 2023
  • Prohibition Partners Discusses The Evolving Cannabis Market Globally At Cannabis Europa

    Richard Zwicky and Stephen Murphy are discussing Cannabis Europa, the ninth edition of Prohibition Partners’ cannabis conference, which is held in the Barbecue venue in London. This year, the show has more North American audiences, including US companies, investors, producers, and ancillary companies. 

    This year, Germany also announced its policy towards legalization for adult use, even though it is more of a decriminalization than actual legalization. The conference is a great opportunity for those interested in the cannabis industry to learn about the latest developments, as well as to enjoy the vibrant atmosphere the Barbecue venue offers.

    They discussed two great shows coming up, and the 8th annual European Cannabis Report was recently published. This report explores the trends happening in each market, issues with the supply chain, and major regulatory reform for both medical and adult use. The report also highlights the growth of medical cannabis in Europe, as well as minor tweaks happening in mature markets that have a greater effect. Ultimately, the report shows that there is no one size fits all policy in cannabis, as each market has its own regulations and procedures.

    28m - Apr 18, 2023
  • Anthony Coniglio Of NewLake Capital Returns

    NewLake Capital with CEOAnthony Coniglio today on The Green Peak with Richard Zwicky only on Cannabis Radio. Mr. Coniglio is CEO and a member of our board of directors. 

    He co-founded NewLake in 2019 and continues to serve as Chief Executive Officer following the merger with GreenAcreage in March 2021. Prior to co-founding NewLake, Mr. Coniglio was the Chief Executive Officer of Primary Capital Mortgage (PCM), a residential mortgage company. 

    Prior to PCM, he was a Managing Director at JPMorgan, leading various businesses, including a start-up platform, to leadership positions and helping grow business line profitability exponentially. 

    During his 14 years at JPMorgan, Anthony was named by Dealmaker Magazine as “Top 40 under 40 on Wall Street” and led complex transactions, such as the financial-crisis restructurings for GMAC and Chrysler Financial, as well as AmeriCredit’s $3.5 billion sales to General Motors. Mr. Coniglio has led numerous initial public offerings for REITs and corporations, including MasterCard’s $5.3 billion initial public offerings.

    24m - Mar 28, 2023
  • KIVA With Co-Founder Kristi Palmer

    More than 1.7 billion people around the world are unbanked and can’t access the financial services they need. Kiva is an international nonprofit, founded in 2005 in San Francisco, with a mission to expand financial access to help underserved communities thrive.

    KIVA does this by crowdfunding loans and unlocking capital for the underserved, improving the quality and cost of financial services, and addressing the underlying barriers to financial access around the world. Through Kiva's work, students can pay for tuition, women can start businesses, farmers are able to invest in equipment and families can afford needed emergency care.

    They believe lending alongside thousands of others is one of the most powerful and sustainable ways to create economic and social good. Lending on Kiva creates a partnership of mutual dignity and makes it easy to touch more lives with the same dollar. Fund a loan, get repaid and fund another.

    24m - Feb 7, 2023
  • Purissima With Founder Robert Evans

    Purissima is revolutionizing the way companies source and use plant-based ingredients, through the development and production of commercially viable, microbial biotechnology. Purissima's mission is to provide the world access to high-quality, pure, safe, and sustainable ingredients for products that improve the quality of life for millions. 

    Purissima has sustainably and effectively recreated 60+ natural ingredients, including those rare or hard to access, at a fraction of the cost and without adverse environmental, varietal, or supply chain impact. The brand's patented and proprietary biotechnology advances critical plant-derived health + wellness solutions while preserving Earth's biodiversity and natural resources.

    27m - Jan 24, 2023
Audio Player Image
The Green Peak
Loading...